Oxytocin Nasal Spray: What the Human Research Shows
Cognitive & Nootropic Research
Oxytocin is one of the few peptides with both a long clinical history and a large human research literature, and almost all of that research delivers it as a nasal spray. This article covers what oxytocin is, what the human intranasal studies have reported, and how our sprays are made up.
Findings
- Oxytocin is a nine-amino-acid peptide closed into a ring by a disulfide bridge, molecular weight 1007.2. It was the first peptide hormone made in a laboratory (du Vigneaud, 1953), work recognised with the 1955 Nobel Prize in Chemistry.
- Most human studies give it intranasally, and a nasal dose reaches the cerebrospinal fluid as well as the blood (Striepens et al., 2013).
- Human studies have reported effects on trust, emotion recognition, appetite and insulin sensitivity. In one trial a single nasal dose cut intake at a test meal by 122 kcal and improved insulin sensitivity (Lawson et al., 2015).
- The 4 mg spray is 400 mcg per mL, about 70 mcg per spray; the 10 mg spray is 1 mg per mL, about 175 mcg per spray. All arrive pre-mixed: no reconstitution needed.
View product →What oxytocin is
Oxytocin is a cyclic peptide of nine amino acids, Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2, closed into a ring by a disulfide bridge between its two cysteines. Its formula is C43H66N12O12S2, and it differs from vasopressin at just two positions.
It is made mainly in the paraventricular and supraoptic nuclei of the hypothalamus and released into the blood from the posterior pituitary, with smaller amounts made in the uterus, placenta, testis and heart. It acts on a single receptor, the oxytocin receptor, which belongs to the G protein-coupled family. Its classic roles are uterine contraction in labour and milk let-down in breastfeeding, and in hospitals it is given by infusion or injection around delivery. In the bloodstream it is short-lived, with a half-life of roughly 1 to 6 minutes.
The nasal route is not new. A commercial oxytocin nasal spray was in use for breastfeeding difficulties by 1960. A 1981 BMJ trial in mothers of premature babies reported milk volumes on days 2 to 5 that were 3.5 times higher in first-time mothers given oxytocin than in those given placebo.
The landmark intranasal studies
| Study | Participants | Design | What was reported |
|---|---|---|---|
| Kosfeld et al., Nature 2005 | Healthy men | Single intranasal dose; a trust game, with a risk game as the control | A substantial increase in trust, not explained by a general willingness to take risks. |
| Guastella et al., Biol Psychiatry 2010 | 16 males aged 12 to 19 with autism | Placebo-controlled crossover | Better scores on the Reading the Mind in the Eyes test. |
| Striepens et al., Sci Rep 2013 | 15 adults (11 oxytocin, 4 placebo) | Single intranasal dose; blood and spinal fluid sampled | Oxytocin rose in both. Blood levels peaked at 15 minutes, spinal fluid levels took up to 75 minutes, and the two did not correlate. |
| Lawson et al., Obesity 2015 | 25 men | Placebo-controlled crossover, single intranasal dose | 122 kcal less eaten at a test meal, a shift toward using fat for fuel, and better insulin sensitivity. |
Longer trials and where the research is heading
Longer trials have added positive findings of their own. A 2020 trial in 106 adult men with autism reported improvements in repetitive behaviour and eye gaze over six weeks of daily nasal oxytocin (Yamasue et al., 2020). In an eight-week trial in 61 adults with obesity, intake at a test meal was 152 kcal lower on oxytocin (Plessow et al., 2024). Current research is focused on timing, dose and which groups respond best.
Does a nasal spray reach the brain?
The human evidence says yes. The 2013 spinal-fluid study showed that a nasal dose raises oxytocin in cerebrospinal fluid, and a 2021 review by Quintana and colleagues concluded that the evidence points to functionally relevant nose-to-brain effects. A 2020 imaging study (Martins et al.) compared a nasal spray, a nasal nebuliser and an intravenous infusion: all three lowered blood flow to the amygdala, and the authors reported robust evidence that the intranasal route reaches specific brain regions.
Handling and storage
Oxytocin is heat-sensitive. How fast it breaks down depends on both temperature and pH, and it is most stable in mildly acidic solution, around pH 4.5 (Hawe et al., 2009). The World Health Organization’s guidance for clinical oxytocin is refrigerated transport and storage at 2 to 8 °C, and the same range suits research solutions: keep the spray, or a reconstituted vial, in the refrigerator.
Spray or vial
We supply oxytocin two ways. The Oxytocin Nasal Spray arrives pre-mixed in a sealed metered atomiser: the 4 mg bottle holds 4 mg in 10 mL of saline (about 57 sprays) at 400 mcg per mL, or approximately 70 mcg per spray; the 10 mg bottle holds 10 mg in 10 mL (about 57 sprays) at approximately 175 mcg per spray. No reconstitution is needed. The Oxytocin vials (2 mg and 10 mg) are lyophilised and is reconstituted with bacteriostatic water; the oxytocin reconstitution guide and the peptide calculator cover the arithmetic. Certificates of analysis are on the lab reports page.
Oxytocin is supplied for laboratory research use only. For more on nasal delivery, see Semax and Selank: nasal spray or injection and our guide to peptide nasal sprays in Canada.
Frequently asked questions
How much oxytocin is in each spray?
The 4 mg size is 400 mcg per mL, so each spray delivers approximately 70 mcg, and the bottle holds about 57 sprays. The 10 mg size is 1 mg per mL, about 175 mcg per spray, with about 57 sprays.
Why is oxytocin studied as a nasal spray?
Most human oxytocin research delivers it intranasally. A 2013 study measured oxytocin rising in cerebrospinal fluid as well as blood after a nasal dose, and the route avoids injection.
What have human studies of oxytocin nasal spray reported?
Published studies have reported increased trust in healthy men (Nature, 2005), better emotion-recognition scores in young people with autism (2010), and lower food intake at a test meal with improved insulin sensitivity in men (2015). Longer trials have added findings on repetitive behaviour, eye gaze and appetite.
Does the oxytocin spray need mixing?
No. It arrives pre-mixed in a sealed metered atomiser. Only the lyophilised vials (2 mg and 10 mg) are reconstituted, with bacteriostatic water.
Where can I buy oxytocin nasal spray in Canada?
Vistara Labs supplies oxytocin as a ready-mixed nasal spray in 4 mg and 10 mg sizes and as lyophilised vials in 2 mg and 10 mg, shipped from within Canada. Laboratory research use only.
Sources: Kosfeld M et al. Oxytocin increases trust in humans. Nature. 2005. PMID 15931222. Guastella AJ et al. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biol Psychiatry. 2010. PMID 19897177. Striepens N et al. Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans. Sci Rep. 2013. PMID 24310737. Lawson EA et al. Oxytocin reduces caloric intake in men. Obesity. 2015. PMID 25865294. Yamasue H et al. Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder. Mol Psychiatry. 2020. PMID 29955161. Plessow F et al. Intranasal oxytocin for obesity. NEJM Evid. 2024. PMID 38815173. Quintana DS et al. Advances in the field of intranasal oxytocin research. Mol Psychiatry. 2021. PMID 32807845. Martins DA et al. Effects of route of administration on oxytocin-induced changes in regional cerebral blood flow in humans. Nat Commun. 2020. PMID 32127545. Hawe A et al. Towards heat-stable oxytocin formulations: analysis of degradation kinetics and identification of degradation products. Pharm Res. 2009. PMID 19343484. Ruis H et al. Oxytocin enhances onset of lactation among mothers delivering prematurely. BMJ. 1981. PMID 6788318. Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev. 2001. PMID 11274341.
All products supplied by Vistara Labs are intended for laboratory research use only. They are not drugs, are not approved for human or veterinary use, and are not intended to diagnose, treat, cure or prevent any condition. Nothing on this page constitutes medical advice or guidance for use in humans.